---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-25-000135"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2025-09-18T23:59:59+00:00"
generated_at: "2026-05-17T06:15:14.683290+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salarius amends merger deal with Decoy; sets preferred conversion floor at $3.75

## Summary
- Fifth Amendment to Merger Agreement sets initial conversion price at $10.50/share for Series A & B Preferred.
- Price protection adjusted using spread between $10.50 baseline and any dilutive subsequent financing.
- Floor price of $3.75/share set as lowest conversion price in price protection calculations.
- Series B Preferred redemption price changed to $10.50 multiplied by 1,000 per share.
- All other Merger Agreement terms remain in full force and effect.

## SEC filing metadata
- accession: 0001615219-25-000135
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2025-09-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/0001615219-25-000135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/flks-20250917.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-25-000135
- JSON: https://secwatch.observer/filing/0001615219-25-000135.json
- Plain text: https://secwatch.observer/filing/0001615219-25-000135.txt

## Key facts
- Equity Issuances
  Decoy Therapeutics Inc. issued preferred stock.
  - Security: preferred stock
  source text: On September 17, 2025, the Company entered into a Fifth Amendment to Agreement and Plan of Merger (the “Fifth Amendment”) to modify the conversion terms of the Company’s form of Certificate of Designations of Series A Non-Voting Convertible Preferred Stock (“Series A Preferred Stock”) and Series B Non-Voting Convertible Preferred Stock (“Series B Preferred Stock”, and together with the Series A Preferred Stock, the “Preferred Stock”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1615219/000161521925000135/0001615219-25-000135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.